Why the Updated COVID-19 Vaccine Is Your Strongest Defense Against Long COVID Skip to main content mRNA pipeline Careers Newsroom Blogs Moderna Supplier Page | Health Care Professionals Investors Clinical trials USA English Search Read our blog...
A new report accuses American drugmaker Moderna of prioritizing profits from COVID-19 vaccines by keeping poor countries waiting. The New York Times says the vaccine maker has sold most of its doses to wealthier nations. Only one million doses have gone to low-income countries...
Why the Updated COVID-19 Vaccine Is Your Strongest Defense Against Long COVID Read our blog NewsJob opportunities Moderna to Report Fourth Quarter and Full Year 2024 Financial Results on Friday, February 14, 2025 29 January 2025 Moderna Awarded Tender for the Supply of Its mRNA COVID-19 Vacci...
Moderna Next-Gen mRNA COVID-19 Vaccine Meets Primary Endpoints in NextCOVE Phase 3 TrialHalsey, GracePatient Care (Online)
‘Unprecedented achievement’: who received the first billion COVID vaccinations? Is one vaccine dose enough if you’ve had COVID? What the science says Mounting evidence suggests Sputnik COVID vaccine is safe and effective Six months of COVID vaccines: what 1.7 billion doses have taught ...
pharmaceutical giant Moderna said its COVID-19 vaccine protects against two new variants of the coronavirus. The company said the vaccine triggered an immune response to "all key emerging variants," including those first identified in the UK and South Africa. The researchers looked ...
Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates Follow the latest updates of theoutbreakon ourtimeline. The Coalition for Epidemic Preparedness Innovations (CEPI) granted funding toInovio Pharmaceuticalsand Moderna for the development of a vaccine against the new co...
approval of its Covid vaccine. On May 7, Pfizer and partner BioNTech said they started the process of seeking full approval for their vaccine for use in people 16 and older in the U.S. If the FDA grants Moderna's request, it would be the Massachusetts-based company's first-ever ...
The FDA green-lit clinical trials of Moderna’s vaccine on March 3, the first out of the gate. Its advanced stage clinical trial started July 27 and it was the first government-funded Phase 3 clinical trial for a Covid-19 vaccine in the US. The company applied to the FDA for emergency...
Moderna secures partial victory in Covid vaccine legal fight Pfizer and BioNTech infringed pharmaceutical group’s mRNA patent, High Court in London rules Save Moderna wins US funding for bird flu vaccine as animal infections grow Federal health officials step up efforts to boost jab stockpiles ...